跳至主要内容
临床试验/EUCTR2009-011543-40-GB
EUCTR2009-011543-40-GB进行中(未招募)1 期

Assessment of platelet inhibitory response to clopidogrel when coadministered with a proton pump inhibitor - Plavix and PPI study

Papworth Hospital0 个研究点目标入组 72 人开始时间: 2010年10月19日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Able to consent
  • Elective PCI
  • Bleeding risk (eScore>15) and indication for PPI when on DAP
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Allergic to omeprazole, rabeprazole or ranitidine
  • Already on a PPI

研究者

相似试验

进行中(未招募)
不适用
Assessing Platelet Inhibitory Response to Clopidogrel – Feasibility, Safety and Cost Analysis of a Tailored Platelet Inhibition Strategy for Elective PCI Patients - Plavix and PrasugrelTo investigate the feasibility, safety and cost of using the platelet assay VerifyNow-P2Y12 to guide optimal P2Y12 platelet inhibition in patients undergoing elective PCI, compared with standard treatment, at a UK tertiary referral cardiology centre.
EUCTR2010-018435-18-GBPapworth Hospital NHS Foundation Trust200
已完成
4 期
Inhibition of platelet activation by clopidogrel in type II diabetes mellitus patientsdiabetes mellitus / diabetes1003553410012653
NL-OMON32343niversitair Medisch Centrum Utrecht24
已完成
4 期
ASsesment of Platelet function and Inhibition in patients Recovering from severe INfectionHeart attack10011082Acute myocardial infarction
NL-OMON50157Vrije Universiteit Medisch Centrum97
进行中(未招募)
1 期
Evaluation of platelet activity in patients recovering from a severe infectioHyperaggregability of thrombocytes triggered by severe infection (i.e. pneumonia or invasive urinary tract infection or a cutaneous infection).
EUCTR2016-004303-32-NLVU university medical center62
进行中(未招募)
不适用
Anti-inflammatory and Anti-platelet effect of Clopidogrel and Aspirin vs Aspirin alone in Symptomatic Polyvascular disease and in patients with multiple recurrent cardiovascular events. - NDPolyvascular disease and in patients with multiple recurrent cardiovascular events.MedDRA version: 9.1Level: LLTClassification code 10032377Term: Other peripheral vascular diseaseMedDRA version: 9.1Level: LLTClassification code 10028600Term: Myocardial ischaemia
EUCTR2008-004626-17-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI